MedPath

EYLEA 114,3 MG/ML SOLUCION INYECTABLE

EYLEA 114,3 MG/ML SOLUCION INYECTABLE

Commercialized
Register Number

112797003

Prescription Type

Uso Hospitalario

Authorization Date

Jan 9, 2024

Dosage Form

SOLUCIÓN INYECTABLE

Route: VÍA INTRAVÍTREA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number112797003
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

AFLIBERCEPTActive
Quantity: 114,3 mg/ml
Name: AFLIBERCEPT

ATC CLASSIFICATION (3)

S01L
S01LA
S01LA05

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.